异荭草素对2型糖尿病大血管病变小鼠主动脉的保护作用及机制研究
To Investigate the Protective Effect and Mechanism of Isoorientin on Aortic in T2DM Macrovascular Disease Mice
DOI: 10.12677/ACM.2022.12101321, PDF,    科研立项经费支持
作者: 谭 娟:青岛大学附属医院内分泌与代谢病科,山东 青岛;临沂市中心医院内分泌科,山东 临沂;车 奎, 迟静薇:青岛大学附属医院医学研究中心,山东 青岛;王颜刚*:青岛大学附属医院内分泌与代谢病科,山东 青岛
关键词: T2DM异荭草素大血管病变炎症T2DM Isoorientin Macroangiopathy Inflammation
摘要: 目的:探讨异荭草素对T2DM大血管病变小鼠主动脉的保护作用及机制。方法:C57BL/6J雄性小鼠随机分为正常对照组(NC组)和实验组。以高脂饲料(含量60%)喂养和链脲佐菌素(STZ)腹腔注射制备2型糖尿病大血管病变模型。将成模的T2DM大血管病变小鼠随机分成模型组和异荭草素治疗组。异荭草素治疗组再分低、中、高剂量,分别按照10、20、40 mg⋅kg−1剂量腹腔注射给药。正常组、模型组给予腹腔注射等量溶剂0.5%羧甲基纤维素钠。实验期间观察动物一般状况并测血糖。8周后处死小鼠取胸主动脉标本。光镜下观察其病理结构,ELisa检测血管组织中AGEs水平,RT-qPCR检测RAGE、IL-6、P65、TNF-α、Vcam-1mRNA的表达水平。结果:镜下观察,与模型对照组相比,异荭草素各治疗组内膜增厚、弹力纤维断裂、泡沫细胞聚集明显减轻。与模型对照组相比,异荭草素干预后随机血糖显著下降(F = 82.20, P < 0.001),血管中AGEs浓度显著降低(F = 60.180,P < 0.001),异荭草素各治疗组血管中RAGE、IL-6、NF-κB p65、TNF-α、Vcam-1等因子的表达水平显著下降(F = 68.05~1692, P < 0.01)。结论:异荭草素可通过抑制炎症反应,改善糖尿病大血管病变。
Abstract: Objective: To investigate the protective effect and mechanism of isoorientin on macrovascular dis-eases in T2DM mice. Methods: Male C57BL/6J mice were randomly divided into normal control group (NC group) and experimental group. Type 2 diabetic macroangiopathopathy model was es-tablished by feeding high-fat diet (60%) and intrabitoneal injection of streptozotocin (STZ). Model T2DM macrovascular disease mice were randomly divided into model group and isoorientin treat-ment group. Isoorientin treatment group was divided into low, medium and high doses by intraper-itoneal injection of 10, 20 and 40 mg⋅kg−1 respectively. Normal group and model group were intra-peritoneally injected with 0.5% sodium carboxymethyl cellulose. During the experiment, the gen-eral condition of animals was observed and blood glucose was measured. After 8 weeks, the mice were sacrificed for thoracic aorta specimens. The pathological structure was observed under light microscope, AGEs levels in vascular tissues were detected by ELisa, and mRNA expression levels of RAGE, IL-6, P65, TNF-α and VCAM-1 were detected by RT-qPCR. Results: Compared with the model control group, the endometrial thickening, elastic fiber fracture and foam cell aggregation in isoorientin treatment groups were significantly reduced. Results: Compared with the model control group, the isoorientin treatment groups random blood glucose decreased significantly (F = 82.20, P < 0.001) and the concentration of AGEs in blood vessels decreased significantly (F = 60.18, P < 0.001). Compared with the model congtrol group, the isoorientin treatment groups also had signifi-cantin decreases in the expression levels of RAGE, IL-6, NF-κB p65, TNF-α, and Vcam-1 in blood ves-sels (F = 68.05~1692, P < 0.01). Conclusion: Isoorientin can improve diabetic macroangiopathy by inhibiting the inflammatory response.
文章引用:谭娟, 车奎, 迟静薇, 王颜刚. 异荭草素对2型糖尿病大血管病变小鼠主动脉的保护作用及机制研究[J]. 临床医学进展, 2022, 12(10): 9140-9146. https://doi.org/10.12677/ACM.2022.12101321

参考文献

[1] Zheng, Y., Ley, S.H. and Hu, F.B. (2018) Global Aetiology and Epidemiology of Type 2 Diabetes Mellitus and Its Complications. Nature Reviews Endocrinology, 14, 88-98. [Google Scholar] [CrossRef] [PubMed]
[2] Madonna, R., Pieragostino, D., Balistreri, C.R., et al. (2018) Diabetic Macroangiopathy: Pathogenetic Insights and Novel Therapeu-tic Approaches with Focus on High Glucose-Mediated Vascular Damage. Vascular Pharmacology, 107, 27-34. [Google Scholar] [CrossRef] [PubMed]
[3] Wolf, D. and Ley, K. (2019) Immunity and Inflammation in Ather-osclerosis. Circulation Research, 124, 315-327. [Google Scholar] [CrossRef
[4] Katakami, N. (2018) Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus. Journal of Atherosclerosis and Thrombosis, 25, 27-39. [Google Scholar] [CrossRef
[5] Scioli, M.G., Cervelli, V., Arcuri, G., et al. (2014) High Insulin-Induced Down-Regulation of Erk-1/IGF-1R/FGFR-1 Signaling Is Required for Oxidative Stress-Mediated Apoptosis of Adi-pose-Derived Stem Cells. Journal of Cellular Physiology, 229, 2077-2087. [Google Scholar] [CrossRef] [PubMed]
[6] Yuan, T., Yang, T., Chen, H., et al. (2019) New Insights into Oxidative Stress and Inflammation during Diabetes Mellitus-Accelerated Atherosclerosis. Redox Biology, 20, 247-260. [Google Scholar] [CrossRef] [PubMed]
[7] Akbari, M. and Hassan, Z.V. (2018) IL-6 Signalling Pathways and the Development of Type 2 Diabetes. Inflammopharmacology, 26, 685-698. [Google Scholar] [CrossRef] [PubMed]
[8] Cui, R., Sun, S.Q., Zhong, N., et al. (2020) The Relationship be-tween Atherosclerosis and Bone Mineral Density in Patients with type 2 Diabetes Depends on Vascular Calcifications and Sex. Osteoporosis International, 31, 1135-1143. [Google Scholar] [CrossRef] [PubMed]
[9] Luc, K., Schramm-Luc, A., Guzik, T.J., et al. (2019) Oxidative Stress and Inflammatory Markers in Prediabetes and Diabetes. Journal of Physiology and Pharmacology, 70, 809-824.
[10] Li, Y., Zhao, Y., Tan, X., et al. (2020) Isoorientin Inhibits Inflammation in Macrophages and Endotoxe-mia Mice by Regulating Glycogen Synthase Kinase 3β. Mediators of Inflammation, 2020, Article ID: 8704146. [Google Scholar] [CrossRef] [PubMed]
[11] Slim, C., Zaouali, M.A., Nassrallah, H., et al. (2020) Protective Poten-tial Effects of Fucoidan in Hepatic Cold Ischemia-Rerfusion Injury in Rats. International Journal of Biological Macro-molecules, 155, 498-507. [Google Scholar] [CrossRef] [PubMed]
[12] Ayissi Owona, B., Angie Abia, W. and Fewou Moundipa, P. (2020) Natural Compounds Flavonoids as Modulators of Inflammasomes in Chronic Diseases. International Im-munopharmacology, 84, Article ID: 106498. [Google Scholar] [CrossRef] [PubMed]
[13] 万思琦, 刘立亚, 刘梦思, 等. 荭草苷的药理作用机制研究[J]. 医学研究杂志, 2018, 47(6): 183-186.
[14] Laddha, A.P. and Kulkarni, Y.A. (2019) Tannins and Vascular Com-plications of Diabetes: An Update. Phytomedicine, 56, 229-245. [Google Scholar] [CrossRef] [PubMed]
[15] Cornelius, V.A., Yacoub, A., Kelaini, S. and Margariti, A. (2021) Diabetic Endotheliopathy: RNA-Binding Proteins as New Therapeutic Targets. The International Journal of Bio-chemistry & Cell Biology, 131, Article ID: 105907. [Google Scholar] [CrossRef] [PubMed]
[16] Poznyak, A., Grechko, A.V., Poggio, P., et al. (2020) The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation. International Journal of Molecular Sciences, 21, Article No. 1835. [Google Scholar] [CrossRef] [PubMed]
[17] Yu, Z.W., Zhang, J., Li, X., et al. (2020) A New Research Hot Spot: The Role of NLRP3 Inflammasome Activation, a Key Step in Pyroptosis, in Diabetes and Diabetic Complications. Life Sciences, 240, Article ID: 117138. [Google Scholar] [CrossRef] [PubMed]
[18] Ding, S., Xu, S., Ma, Y., et al. (2019) Modulatory echanisms of the NLRP3 Inflammasomes in Diabetes. Biomolecules, 9, Article No. 850. [Google Scholar] [CrossRef] [PubMed]
[19] Shi, Y. and Vanhoutte, P.M. (2017) Macro- and Microvascular Endo-thelial Dysfunction in Diabetes. Journal of Diabetes, 9, 434-449. [Google Scholar] [CrossRef] [PubMed]
[20] Rhee, S.Y. and Kim, Y.S. (2018) The Role of Advanced Glycation end Products in Diabetic Vascular Complications. Diabetes & Metabolism Journal, 42, 188-195. [Google Scholar] [CrossRef] [PubMed]
[21] Zeng, C., Li, Y., Ma, J., et al. (2019) Clinical /Translational Aspects of Advanced Glycation End-Products. Trends in Endocrinology and Metabolism, 30, 959-973. [Google Scholar] [CrossRef] [PubMed]
[22] Wu, N., Shen, H., Liu, H., et al. (2016) Acute Blood Glucose Fluc-tuation Enhances Rat Aorta Endothelial Cell Apoptosis, Oxidative Stress and Proinflammatory Cytokine Expression in Vivo. Cardiovascular Diabetology, 15, Article No. 109. [Google Scholar] [CrossRef] [PubMed]